Search Results - Clinical+Specialty+%3e+Women%27s+Health

3 Results

Sort By:

I have demonstrated that BRCA1-mutant triple-negative breast cancer (TNBC) cells are highly sensitive to cyclosporine (CsA) and non-immunosuppressive CsA-derivatives (NIM811 or Alisporivir). To determine whether CsA would also be effective in treating BRCA1-mutant TNBC cells in vivo, I set up a pilot study using a preclinical xenograft model to investigate...

Published: 10/5/2021 | Inventor(s): Kimi Yuk-Ling Kong

Keywords(s):

Category(s): Clinical Specialty > Oncology, Clinical Specialty > Women's Health, Clinical Specialty > Endocrinology, Life Sciences Research Tools > Drug Screening, Therapeutics > Small Molecule

Advanced Cervical Ripening System (ACRS)

UT Health San Antonio researchers have developed a unique method for advanced cervical ripening which causes the effacement and thinning that occurs in natural child birth. This advanced cervical ripening system is superior to traditional methods because the unique design allows for uniform ripening by adapting to the geometry of each patient, and...

Published: 2/8/2023 | Inventor(s): Brent Nowak, Leonid Bunegin

Keywords(s):

Category(s): Medical Devices > Surgical Equipment, Clinical Specialty > Women's Health

Endocrine Therapy Diagnostic for ER+ Breast Cancer

UT Health San Antonio seeks to partner with a diagnostic products company to develop and commercialize a clinical diagnostic with the potential to determine if a patient with estrogen receptor (ER) positive breast cancer is suitable for treatment with endocrine therapy (e.g., tamoxifen and/or the aromatase inhibitors anastrozole (Arimidex®), letrozole...

Published: 5/28/2024 | Inventor(s): Amy Trauernicht, Thomas Boyer

Keywords(s): Biologics, Drugs

Category(s): Diagnostics > Assay, Clinical Specialty > Oncology, Clinical Specialty > Women's Health